Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 6, 2010, Pages 804-812

  Wöhrle, Jochen ^a   Merkle, Nico ^a   Mailänder, Volker ^b   Nusser, Thorsten ^a   Schauwecker, Peter ^b   von Scheidt, Fabian ^a   Schwarz, Klaus ^b   Bommer, Martin ^a   Wiesneth, Markus ^b   Schrezenmeier, Hubert ^b   Hombach, Vinzenz ^a  

^a UNIVERSITY OF ULM   (Germany)

^b German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CANCER; BRAIN INFARCTION SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION INJURY; STEM CELL TRANSPLANTATION;

ADULT; AGED; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77649181194     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.060     Document Type: Article

References (21)

1. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Süselbeck T., Assmus B., Tonn T., Dimmeler S., and Zeiher A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
2. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grøgaard H.K., Bjørnerheim R., Brekke M., Müller C., Hopp E., Ragnarsson A., Brinchmann J.E., and Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
3. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., and Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
4. Tendera M., Wojakowski W., Ruzyllo W., Chojnowska L., Kepka C., Tracz W., Musiałek P., Piwowarska W., Nessler J., Buszman P., Grajek S., Breborowicz P., Majka M., and Ratajczak M.Z. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30 (2009) 1313-1321
5. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
6. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
7. Ge J., Li Y., Qian J., Shi J., Wang Q., Niu Y., Fan B., Liu X., Zhang S., Sun A., and Zou Y. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 92 (2006) 1764-1767
8. Huikuri H.V., Kervinen K., Niemelä M., Ylitalo K., Säily M., Koistinen P., Savolainen E.R., Ukkonen H., Pietilä M., Airaksinen J.K., Knuuti J., and Mäkikallio T.H. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 29 (2008) 2723-2732
9. Dill T., Schächinger V., Rolf A., Möllmann S., Thiele H., Tillmanns H., Assmus B., Dimmeler S., Zeiher A.M., and Hamm C. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J 157 (2009) 541-547
10. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., and Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29 (2008) 1807-1818
11. Meluzín J., Mayer J., Groch L., Janousek S., Hornácek I., Hlinomaz O., Kala P., Panovský R., Prásek J., Kamínek M., Stanícek J., Klabusay M., Korístek Z., Navrátil M., Dusek L., and Vinklárková J. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 152 (2006) 975 e9-975.15
12. Hombach V., Grebe O., Merkle N., Waldenmaier S., Höher M., Kochs M., Wöhrle J., and Kestler H.A. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26 (2005) 549-557
13. Britten M.B., Abolmaali N.D., Assmus B., Lehmann R., Honold J., Schmitt J., Vogl T.J., Martin H., Schächinger V., Dimmeler S., and Zeiher A.M. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
14. Wöhrle J., Nusser T., Hoffmann S., and Kochs M. Angiographic results of the cobalt chromium vision and mini-vision stents. Can J Cardiol 25 (2009) 581-584
15. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., and Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
16. Bellenger N.G., Burgess M.I., Ray S.G., Lahiri A., Coats A.J., Cleland J.G., and Pennell D.J. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J 21 (2000) 1387-1396
17. Kang H.J., Lee H.Y., Na S.H., Chang S.A., Park K.W., Kim H.K., Kim S.Y., Chang H.J., Lee W., Kang W.J., Koo B.K., Kim Y.J., Lee D.S., Sohn D.W., Han K.S., Oh B.H., Park Y.B., and Kim H.S. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 Suppl (2006) I145-I151
18. Ndrepepa G., Mehilli J., Martinoff S., Schwaiger M., Schömig A., and Kastrati A. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol 50 (2007) 149-156
19. Engelmann M.G., Theiss H.D., Hennig-Theiss C., Huber A., Wintersperger B.J., Werle-Ruedinger A.E., Schoenberg S.O., Steinbeck G., and Franz W.M. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 48 (2006) 1712-1721
20. Seeger F.H., Tonn T., Krzossok N., Zeiher A.M., and Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28 (2007) 766-772
21. Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther 17 (2009) 758-766